Feedback / Questions
Krintafel (tafenoquine) - 60° Pharma
https://www.globenewswire.com/news-release/2024/06/11/2896700/0/en/60-Degrees-Pharmaceuticals-Receives-FDA-Orphan-Drug-Designation-for-Tafenoquine-for-Treatment-of-Patients-with-Acute-Babesiosis.html
Jun 11, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next